Ataluren, formerly known as PTC124, is a pharmaceutical drug for the treatment of Duchenne muscular dystrophy and potentially other genetic disorders. It was designed by PTC Therapeutics and is sold under the trade name Translarna in the European Union.

CAS：775304-57-9
中文别名：
英文别名：3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid;
分子式：C15H9FN2O3
分子量：284.242
精确质量：284.06
Psa：76.22
Logp：3.2409

MDL号：MFCD09864996

密度：1.379
沸点：503.7ºC at 760 mmHg
折射率：1.603

海关编码：2934999090